Atrial Fibrillation in Cardiac Channelopathies
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Fibrinaloid Microclots and Atrial Fibrillation.
Kell D, Lip G, Pretorius E Biomedicines. 2024; 12(4).
PMID: 38672245 PMC: 11048249. DOI: 10.3390/biomedicines12040891.
Where There's Smoke, There's Fire? Significance of Atrial Fibrillation in Young Patients.
Wutzler A, von Ulmenstein S, Attanasio P, Huemer M, Parwani A, Volk K Clin Cardiol. 2016; 39(4):229-33.
PMID: 26848930 PMC: 6490740. DOI: 10.1002/clc.22516.
References
1.
Gallagher M, Magliano G, Yap Y, Padula M, Morgia V, Postorino C
. Distribution and prognostic significance of QT intervals in the lowest half centile in 12,012 apparently healthy persons. Am J Cardiol. 2006; 98(7):933-5.
DOI: 10.1016/j.amjcard.2006.04.035.
View
2.
Chen Y, Xu S, Bendahhou S, Wang X, Wang Y, Xu W
. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science. 2003; 299(5604):251-4.
DOI: 10.1126/science.1077771.
View
3.
Sacher F, Probst V, Bessouet M, Wright M, Maluski A, Abbey S
. Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population. Europace. 2009; 11(4):489-94.
DOI: 10.1093/europace/eup034.
View
4.
Yang Y, Li J, Lin X, Yang Y, Hong K, Wang L
. Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation. J Hum Genet. 2009; 54(5):277-83.
DOI: 10.1038/jhg.2009.26.
View
5.
Matsuo K, Kurita T, Inagaki M, KAKISHITA M, Aihara N, Shimizu W
. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J. 1999; 20(6):465-70.
DOI: 10.1053/euhj.1998.1332.
View